These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 24367090)
1. Regulation of PTEN inhibition by the pleckstrin homology domain of P-REX2 during insulin signaling and glucose homeostasis. Hodakoski C; Hopkins BD; Barrows D; Mense SM; Keniry M; Anderson KE; Kern PA; Hawkins PT; Stephens LR; Parsons R Proc Natl Acad Sci U S A; 2014 Jan; 111(1):155-60. PubMed ID: 24367090 [TBL] [Abstract][Full Text] [Related]
2. Structural and biochemical characterization of the pleckstrin homology domain of the RhoGEF P-Rex2 and its regulation by PIP Cash JN; Sharma PV; Tesmer JJG J Struct Biol X; 2019; 1():100001. PubMed ID: 34958187 [TBL] [Abstract][Full Text] [Related]
3. Substrate specificity and recognition is conferred by the pleckstrin homology domain of the Dbl family guanine nucleotide exchange factor P-Rex2. Joseph RE; Norris FA J Biol Chem; 2005 Jul; 280(30):27508-12. PubMed ID: 15897194 [TBL] [Abstract][Full Text] [Related]
5. CELF2 suppresses non-small cell lung carcinoma growth by inhibiting the PREX2-PTEN interaction. Yeung YT; Fan S; Lu B; Yin S; Yang S; Nie W; Wang M; Zhou L; Li T; Li X; Bode AM; Dong Z Carcinogenesis; 2020 May; 41(3):377-389. PubMed ID: 31241130 [TBL] [Abstract][Full Text] [Related]
7. Activation of the PI3K pathway in cancer through inhibition of PTEN by exchange factor P-REX2a. Fine B; Hodakoski C; Koujak S; Su T; Saal LH; Maurer M; Hopkins B; Keniry M; Sulis ML; Mense S; Hibshoosh H; Parsons R Science; 2009 Sep; 325(5945):1261-5. PubMed ID: 19729658 [TBL] [Abstract][Full Text] [Related]
8. Regulation of phosphoinositide metabolism, Akt phosphorylation, and glucose transport by PTEN (phosphatase and tensin homolog deleted on chromosome 10) in 3T3-L1 adipocytes. Ono H; Katagiri H; Funaki M; Anai M; Inukai K; Fukushima Y; Sakoda H; Ogihara T; Onishi Y; Fujishiro M; Kikuchi M; Oka Y; Asano T Mol Endocrinol; 2001 Aug; 15(8):1411-22. PubMed ID: 11463863 [TBL] [Abstract][Full Text] [Related]
9. PTEN, but not SHIP2, suppresses insulin signaling through the phosphatidylinositol 3-kinase/Akt pathway in 3T3-L1 adipocytes. Tang X; Powelka AM; Soriano NA; Czech MP; Guilherme A J Biol Chem; 2005 Jun; 280(23):22523-9. PubMed ID: 15824124 [TBL] [Abstract][Full Text] [Related]
10. Hydrogen sulfide and L-cysteine increase phosphatidylinositol 3,4,5-trisphosphate (PIP3) and glucose utilization by inhibiting phosphatase and tensin homolog (PTEN) protein and activating phosphoinositide 3-kinase (PI3K)/serine/threonine protein kinase (AKT)/protein kinase Cζ/λ (PKCζ/λ) in 3T3l1 adipocytes. Manna P; Jain SK J Biol Chem; 2011 Nov; 286(46):39848-59. PubMed ID: 21953448 [TBL] [Abstract][Full Text] [Related]
11. Lipid phosphatases as a possible therapeutic target in cases of type 2 diabetes and obesity. Sasaoka T; Wada T; Tsuneki H Pharmacol Ther; 2006 Dec; 112(3):799-809. PubMed ID: 16842857 [TBL] [Abstract][Full Text] [Related]
12. Phosphatase and tensin homolog regulation of islet growth and glucose homeostasis. Kushner JA; Simpson L; Wartschow LM; Guo S; Rankin MM; Parsons R; White MF J Biol Chem; 2005 Nov; 280(47):39388-93. PubMed ID: 16170201 [TBL] [Abstract][Full Text] [Related]
13. Impact of lipid phosphatases SHIP2 and PTEN on the time- and Akt-isoform-specific amelioration of TNF-alpha-induced insulin resistance in 3T3-L1 adipocytes. Ikubo M; Wada T; Fukui K; Ishiki M; Ishihara H; Asano T; Tsuneki H; Sasaoka T Am J Physiol Endocrinol Metab; 2009 Jan; 296(1):E157-64. PubMed ID: 19001549 [TBL] [Abstract][Full Text] [Related]
14. Regulation of insulin signaling and glucose transporter 4 (GLUT4) exocytosis by phosphatidylinositol 3,4,5-trisphosphate (PIP3) phosphatase, skeletal muscle, and kidney enriched inositol polyphosphate phosphatase (SKIP). Ijuin T; Takenawa T J Biol Chem; 2012 Mar; 287(10):6991-9. PubMed ID: 22247557 [TBL] [Abstract][Full Text] [Related]
15. Understanding P-Rex regulation: structural breakthroughs and emerging perspectives. Jones GD; Ellisdon AM Biochem Soc Trans; 2024 Aug; 52(4):1849-1860. PubMed ID: 39023851 [TBL] [Abstract][Full Text] [Related]
16. PTEN inhibits PREX2-catalyzed activation of RAC1 to restrain tumor cell invasion. Mense SM; Barrows D; Hodakoski C; Steinbach N; Schoenfeld D; Su W; Hopkins BD; Su T; Fine B; Hibshoosh H; Parsons R Sci Signal; 2015 Mar; 8(370):ra32. PubMed ID: 25829446 [TBL] [Abstract][Full Text] [Related]
17. Muscle-specific Pten deletion protects against insulin resistance and diabetes. Wijesekara N; Konrad D; Eweida M; Jefferies C; Liadis N; Giacca A; Crackower M; Suzuki A; Mak TW; Kahn CR; Klip A; Woo M Mol Cell Biol; 2005 Feb; 25(3):1135-45. PubMed ID: 15657439 [TBL] [Abstract][Full Text] [Related]
18. The Phosphatidylinositol (3,4,5)-Trisphosphate-dependent Rac Exchanger 1·Ras-related C3 Botulinum Toxin Substrate 1 (P-Rex1·Rac1) Complex Reveals the Basis of Rac1 Activation in Breast Cancer Cells. Lucato CM; Halls ML; Ooms LM; Liu HJ; Mitchell CA; Whisstock JC; Ellisdon AM J Biol Chem; 2015 Aug; 290(34):20827-20840. PubMed ID: 26112412 [TBL] [Abstract][Full Text] [Related]